Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Purple Innovation (PRPL) Asset Writedowns and Impairment (2024 - 2025)

Purple Innovation (PRPL) has disclosed Asset Writedowns and Impairment for 2 consecutive years, with $4.7 million as the latest value for Q4 2025.

Quarterly Asset Writedowns and Impairment rose 140.68% to $4.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.5 million through Dec 2025, changed N/A year-over-year, with the annual reading at $8.5 million for FY2025, 0.0% changed from the prior year.
Asset Writedowns and Impairment hit $4.7 million in Q4 2025 for Purple Innovation, up from -$41000.0 in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $8.5 million in Q1 2025 to a low of -$11.6 million in Q4 2024.